206 related articles for article (PubMed ID: 34383966)
21. Barrett's oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review.
Tullie L; Kelay A; Bethell GS; Major C; Hall NJ
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34370830
[TBL] [Abstract][Full Text] [Related]
22. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
23. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.
Duits LC; Phoa KN; Curvers WL; Ten Kate FJ; Meijer GA; Seldenrijk CA; Offerhaus GJ; Visser M; Meijer SL; Krishnadath KK; Tijssen JG; Mallant-Hent RC; Bergman JJ
Gut; 2015 May; 64(5):700-6. PubMed ID: 25034523
[TBL] [Abstract][Full Text] [Related]
24. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
[TBL] [Abstract][Full Text] [Related]
25. Barrett's oesophagus: can meaningful screening and surveillance guidelines be formulated based on new data and rejigging the old paradigm?
Rajendra S
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):65-75. PubMed ID: 25743457
[TBL] [Abstract][Full Text] [Related]
26. The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.
Theron BT; Padmanabhan H; Aladin H; Smith P; Campbell E; Nightingale P; Cooper BT; Trudgill NJ
United European Gastroenterol J; 2016 Dec; 4(6):754-761. PubMed ID: 28408992
[TBL] [Abstract][Full Text] [Related]
27. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.
Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355
[TBL] [Abstract][Full Text] [Related]
28. Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma.
Denver P; Donnelly M; Murray LJ; Anderson LA
World J Gastroenterol; 2013 Mar; 19(11):1770-7. PubMed ID: 23555165
[TBL] [Abstract][Full Text] [Related]
29. Dietary antioxidant intake and the risk of developing Barrett's oesophagus and oesophageal adenocarcinoma.
Kang JH; Luben R; Alexandre L; Hart AR
Br J Cancer; 2018 Jun; 118(12):1658-1661. PubMed ID: 29780162
[TBL] [Abstract][Full Text] [Related]
30. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Pot RG; Moons LM; van Zoest KP; Hansen B; van Dekken H; Siersema PD; Kusters JG; Kuipers EJ
J Hum Genet; 2012 Jan; 57(1):26-32. PubMed ID: 22129558
[TBL] [Abstract][Full Text] [Related]
31. Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.
Rogerson C; Ogden S; Britton E; ; Ang Y; Sharrocks AD
Elife; 2020 Sep; 9():. PubMed ID: 32880368
[TBL] [Abstract][Full Text] [Related]
32. TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma.
Rossi E; Villanacci V; Bassotti G; Donato F; Festa A; Cengia G; Grisanti S; Cestari R
Histopathology; 2010 Jul; 57(1):81-9. PubMed ID: 20557373
[TBL] [Abstract][Full Text] [Related]
33. 'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study.
van Putten M; Johnston BT; Murray LJ; Gavin AT; McManus DT; Bhat S; Turkington RC; Coleman HG
United European Gastroenterol J; 2018 May; 6(4):519-528. PubMed ID: 29881607
[TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
Januszewicz W; Kaminski MF; Wieszczy P; Wronska E; Bielasik A; Wojciechowska U; Didkowska J; Orlowska J; Regula J
Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 27377059
[TBL] [Abstract][Full Text] [Related]
35. Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study.
Hadjinicolaou AV; van Munster SN; Achilleos A; Santiago Garcia J; Killcoyne S; Ragunath K; Bergman JJGHM; Fitzgerald RC; di Pietro M
EBioMedicine; 2020 Jun; 56():102765. PubMed ID: 32460165
[TBL] [Abstract][Full Text] [Related]
36. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
37. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.
Parasa S; Desai M; Vittal A; Chandrasekar VT; Pervez A; Kennedy KF; Gupta N; Shaheen NJ; Sharma P
Gut; 2019 Dec; 68(12):2122-2128. PubMed ID: 30872393
[TBL] [Abstract][Full Text] [Related]
38. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
[TBL] [Abstract][Full Text] [Related]
39. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
Whiteman DC; Kendall BJ
Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol.
Nieto T; Tomlinson CL; Dretzke J; Bayliss S; Dilworth M; Beggs AD; Tucker O
BMJ Open; 2016 Dec; 6(12):e013361. PubMed ID: 27927666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
